Cerity Partners’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.9M Sell
1,192,279
-7,037
-0.6% -$78.5K 0.01% 720
2026
Q1
$13M Buy
1,199,316
+41,912
+4% +$359K 0.02% 592
2025
Q4
$7.07M Sell
1,157,404
-98,023
-8% -$585K 0.01% 800
2025
Q3
$6.5M Buy
1,255,427
+7,653
+0.6% +$44K 0.01% 759
2025
Q2
$7.4M Sell
1,247,774
-98,767
-7% -$595K 0.01% 649
2025
Q1
$11.1M Buy
1,346,541
+25,345
+2% +$213K 0.02% 463
2024
Q4
$10.1M Sell
1,321,196
-17,648
-1% -$142K 0.02% 477
2024
Q3
$10.2M Buy
1,338,844
+606,054
+83% +$5.58M 0.02% 481
2024
Q2
$7.59M Sell
732,790
-706,243
-49% -$7.74M 0.02% 496
2024
Q1
$17.2M Buy
+1,439,033
New +$16M 0.05% 325
2023
Q2
Sell
-3,683
Closed -$1.11M 1888
2023
Q1
$1.11M Buy
+3,683
New +$53.8K ﹤0.01% 933

Other funds holding PTEN

Cerity Partners's PTEN Position: Q2 2026 in Review

Cerity Partners reduced its Patterson-UTI (PTEN) stake by 0.59% in Q2 2026, selling an estimated $78.5K and leaving 1,192,279 shares worth $10.9M. The position accounts for 0.01% of the portfolio, ranked #720.

Cerity Partners first reported a position in PTEN in Q1 2023 and has held it in 11 quarters since. The position peaked at $17.2M in Q1 2024. 405 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Cerity Partners held 1,192,279 shares of Patterson-UTI worth $10.9M as of Q2 2026.
  • Cerity Partners sold 7,037 Patterson-UTI shares in Q2 2026, an estimated $78.5K.
  • Patterson-UTI made up 0.01% of Cerity Partners's portfolio in Q2 2026, its #720 holding.
  • Cerity Partners first reported a position in Patterson-UTI in Q1 2023 and has held it in 11 quarters since.
  • Cerity Partners's Patterson-UTI position peaked at $17.2M in Q1 2024.
  • 405 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.